Meridian Bioscience (VIVO) Posts Q4 adj.-EPS of $0.15, Shy of Views; Declares $0.19 Quarterly Dividend; 3.2% Yield; Reaffirms FY11 Outlook
Meridian Bioscience (Nasdaq: VIVO) reports Q4 non-GAAP EPS of $0.15, versus the consensus of $0.18. Revenue for the quarter came in at $35.5 million, compared to the consensus of $38.37 million.
The Board of Directors declared the regular quarterly cash dividend of $0.19 per share, $0.76 annualized.
The dividend is payable December 3, 2010 to shareholders of record on November 22, 2010. The ex-dividend date is November 18, 2010.
Yield on the dividend is 3.2%.
Reaffirms FY11 outlook.... Read more
VIVO
Latest Price: $ 3.36
Dividend Yield (TTM): 0.00%
- No dividends the last 12 months.
Source: Yahoo Finance. Stock prices and dividends can be delayed, cached or incomplete.
Older articles featuring VIVO:
These Are The Top 3 Sectors For Dividend Growth Investors Now'Safer' Dividend Healthcare Dog's 55% Top Gain Equals Sum Of Four Tailing It In May
Healthcare Dogs See Medical Care Tops By Yield But Big Pharma Tops By Gains For April
National Research Leads 'Safe' Dividend Healthcare Dogs By Yield, Aceto Leads By Gains, In February
5%+ Dividend Yield Portfolio: Taking Profits As Market Valuations Flash Warnings (Jan 2017 Review)
Stocks Trading Ex-Dividend on 11/17/2016
Stocks Trading Ex-Dividend on 8/4/2016
Big Pharma Dominates Healthcare But Caregivers Are Top Sector Yield Dogs In July
Stocks Trading Ex-Dividend on 5/5/2016
Stocks Trading Ex-Dividend on 2/4/2016